A slimy, hydrated mucus gel lines all wet epithelia in the human body, including the eyes, lungs, and gastrointestinal and urogenital tracts. Mucus forms the first line of defence while housing trillions of microorganisms that constitute the microbiota 1 . Rarely do these microorganisms cause infections in healthy mucus 1 , suggesting that mechanisms exist in the mucus layer that regulate virulence. Using the bacterium Pseudomonas aeruginosa and a three-dimensional (3D) laboratory model of native mucus, we determined that exposure to mucus triggers downregulation of virulence genes that are involved in quorum sensing, siderophore biosynthesis and toxin secretion, and rapidly disintegrates biofilms-a hallmark of mucosal infections. This phenotypic switch is triggered by mucins, which are polymers that are densely grafted with O-linked glycans that form the 3D scaffold inside mucus. Here, we show that isolated mucins act at various scales, suppressing distinct virulence pathways, promoting a planktonic lifestyle, reducing cytotoxicity to human epithelia in vitro and attenuating infection in a porcine burn model. Other viscous polymer solutions lack the same effect, indicating that the regulatory function of mucin does not result from its polymeric structure alone. We identify that interactions with P. aeruginosa are mediated by mucin-associated glycans (mucin glycans). By isolating glycans from the mucin backbone, we assessed the collective activity of hundreds of complex structures in solution. Similar to their grafted counterparts, free mucin glycans potently regulate bacterial phenotypes even at relatively low concentrations. This regulatory function is likely dependent on glycan complexity, as monosaccharides do not attenuate virulence. Thus, mucin glycans are potent host signals that 'tame' microorganisms, rendering them less harmful to the host.
may arise from phenotypic regulation by mucus. Mucus-mediated biofilm dispersal is dependent on an intact flagellum ( Fig. 1c) , indicating that mucin triggers an active motility-driven escape, rather than mechanical disruption. To test whether mucus affects only biofilms or whether it more broadly regulates virulence traits, we measured the expression of genes that are important for establishing infection 2 . This revealed that intestinal mucus transcriptionally suppresses quorum sensing (lasR), siderophore biosynthesis (pvdA) and type-3 secretion (pcrV; Fig. 1e ). Native gastric and salivary mucus similarly suppressed major infection-related genes ( Fig. 1e ), suggesting that virulence suppression is conserved across various mucosal surfaces. Together, these findings demonstrate that mucus contains factors that modulate bacterial behaviours at the levels of gene expression and phenotype.
To identify specific regulatory factors within complex mucus, we tested mucus fractions that were separated according to molecular weight. The primary bioactive component of whole mucus was larger than 100 kDa ( Fig. 1f ), indicating mucin polymers as possible candidates. Mucins are a major high-molecular-mass component of mucus that disperse cells in isolation 4 . Adding purified mucins back into depleted mucus was sufficient to restore biofilm dispersal and suppression of virulence genes ( Fig. 1f-h) , providing strong evidence that mucin glycopolymers constitute key regulatory cues inside mucus. Here the use of natively purified mucins was critical because commercially available mucins harbour reduced chemical complexity owing to the harsh purification process 5 .
To directly test whether mucins trigger a global transcriptional response, we performed RNA sequencing (RNA-seq) on P. aeruginosa that were grown with or without (0.5% w/v) MUC5AC or MUC5B, which are the most abundant gel-forming mucins secreted in niches colonized by P. aeruginosa, including the nasal and oral cavities, respiratory tract, eyes and middle ear ( Fig. 2a,b ). Both mucins triggered a genome-wide response ( Fig. 2c , Supplementary Table  1 ) and suppressed many virulence pathways, including type-1, -2, -3 and -6 secretion systems, siderophore biosynthesis (pyoverdine and pyochelin) and quorum sensing ( Fig. 2d , Supplementary  Table 2 ). Among the upregulated genes, we detected enrichment in the denitrification pathway ( Supplementary Table 3 ), consistent with inverse regulation by quorum sensing 6 . Several metabolic genes were also differentially regulated, including those associated with fumarate metabolism and amino acid and C 5 -carboxylate transport ( Supplementary Table 1 ). These results are consistent with metabolic changes, which often correlate with changes in Letters Nature Microbiology virulence 7 . Importantly, we found no enrichment in virulence pathways among upregulated genes ( Supplementary Table 3 ). There were differences in the exact genes that were differentially regulated, as well as differences in the magnitudes of those changes after exposure to MUC5AC or MUC5B ( Fig. 2c, Supplementary Fig. 2 , Supplementary Table 4 ), suggesting differences in mucin biochemistry and specific regulatory function. We replicated this effect with various media, time points and bacterial strains ( Supplementary  Fig. 3 , Supplementary Tables 5-7) , demonstrating that mucin suppresses the expression of virulence genes across a range of experimental conditions.
We validated the regulation of virulence using quantitative PCR (qPCR; Supplementary Fig. 4 ). To confirm the phenotypic relevance of these changes, we combined functional biochemical assays and infection models ( Fig. 2e,i) . Protease activity and siderophore production were lower in supernatants from P. aeruginosa exposed to mucin than in supernatants from bacteria grown in medium alone ( Supplementary Fig. 5 ). Consistent with the downregulation of The natural mucus barrier (left) hosts a diverse range of microorganisms while limiting infections at the mucosa. Mucins (middle) are the major structural component of mucus and are densely grafted with complex glycans (right). b, Defects in mucus production are associated with disease and biofilm formation. c, Representative images of green fluorescent protein (GFP)-expressing P. aeruginosa biofilms after 3 h treatment with either buffer or native mucus reveal that native intestinal mucus reduces the biomass of biofilm in the wild-type (WT) strain, but not in the flagellar mutant (ΔfliD). Similar results were observed in different fields of view across three independent replicates. Scale bar, 20 μm. d, Native intestinal mucus solutions disperse biofilm biomass into the planktonic state. Percentage dispersal is based on the ratio of planktonic cells to total biomass (planktonic cells + remaining biofilm cells). Data are from n = 12 (buffer) and n = 6 (intestinal mucus) biologically independent replicates. Data are mean ± s.e.m.; significance was assessed using two-sided Student's t-tests; ****P < 0.0001. e, Native mucus solutions suppress key virulence traits relative to mucus solubilization buffer. f, The depletion of intestinal mucus components of ≥100 kDa prevents biofilm dispersal. Supplementation of mucus filtrates with exogenous purified MUC2 partially restores biofilm dispersal. Data are mean ± s.e.m. and were calculated from six biologically independent replicates. g, The depletion of intestinal mucus components of ≥100 kDa results in increased expression of virulence genes. Supplementation of mucus filtrates with exogenous purified MUC2 partially restores the downregulation of virulence genes. *P < 0.05, **P < 0.01. h, The depletion of gastric mucus components of ≥100 kDa increases the expression of virulence genes. Supplementation of mucus filtrates with exogenous purified MUC5AC restores the downregulation of virulence genes. For e,g,h, data are log 2 -transformed qPCR measurements of relative gene expression (fold change (FC)); data are mean ± s.e.m. and were calculated from n = 6 (gastric mucus), n = 3 (intestinal mucus) and n = 3 (saliva) biologically independent replicates. For g,h, significance was assessed using two-sided Student's t-tests followed by multiple comparison correction using the Holm-Sidak method.
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biofilm formation, MUC5AC suppressed P. aeruginosa PAO1 association to surfaces made of glass ( Supplementary Fig. 6 ) and plastic ( Supplementary Fig. 7 ) and reduced attachment to live HT-29 human epithelial cells in a concentration-dependent manner (Fig. 2f ). Mucins promoted a larger vertical distribution of P. aeruginosa cells than those grown in medium alone, shifting them to a suspended Supplementary Table 1 . Fold-change data are average measurements. FDR-adjusted P values were determined using the Benjamini-Hochberg P-value adjustment method. Data are from n = 6 (no mucin treatment), n = 3 (MUC5AC-treated) and n = 3 (MUC5B-treated) biologically independent replicates. Correspondence plots of the fold-change values are provided in Supplementary Fig. 2 . Principal component analysis of expression data is provided in Supplementary Fig. 13 . The Venn diagrams contain the total number of genes that are differentially expressed (FDR-adjusted P < 0.05) after exposure to 0.5% w/v MUC5AC (purple) or MUC5B (orange). The significance of overlap was assessed using a hypergeometric test. Functional enrichment analysis of the non-overlapping regions of the Venn diagrams is provided Supplementary Fig. 2 . d, Functional enrichment analyses identify key virulence pathways among downregulated genes. Significance of enrichment was assessed using one-sided Mann-Whitney U-tests, for which ranking was calculated on the basis of mean log 2 -transformed fold changes from n = 6 (no mucin treatment), n = 3 (MUC5ACtreated) and n = 3 (MUC5B-treated) biologically independent replicates. Bars, FDR-adjusted P values. The red dashed line indicates FDR-adjusted P = 0.05. e, P. aeruginosa pathogenicity was evaluated in cell culture (containing a single human epithelial cell type, HT-29). f, Exposure to increasing MUC5AC concentrations inhibited P. aeruginosa attachment to HT-29 cells. The centre line indicates the median, the box limits indicate the upper and lower quartiles and the whiskers indicate 1.5× the interquartile range. Data are from n = 7 (no MUC5AC), n = 4 (0.01% MUC5AC), n = 4 (0.05% MUC5AC), n = 4 (0.1% MUC5AC) and n = 7 (0.5% MUC5AC) biologically independent replicates. Significance was assessed in relation to the medium-alone control using ordinary one-way analysis of variance (ANOVA), followed by Dunnett's multiple comparisons test; ***P < 0.001. g, MUC5AC protects HT-29 epithelial cells from death in a concentration-dependent manner. Dotted lines indicate the 95% confidence interval for the dose-response curve. Data are based on bulk measurements of propidium iodide fluorescence 7.5 h after infection. Data are mean ± s.e.m.; n = 4 biologically independent replicates. IC 50 , halfmaximum inhibitory concentration. h, MUC5AC maintains the intact epithelial cell monolayer and prevents the onset of HT-29 cellular rounding, bacterial attachment and HT-29 death. Representative confocal microscopy of HT-29 epithelial cells (bright field), GFP-expressing P. aeruginosa PAO1 cells (green) and propidium iodide staining (red) after exposing HT-29 cells to P. aeruginosa for 5 h (top, medium alone) or 6 h (bottom, medium with MUC5AC) as indicated. Similar results were observed in different fields of view across three independent replicates. Scale bar, 20 μm. i, Bacterial viability was monitored in a live dermal wound model (containing living tissue, immune cells and secreted factors). j, Bacterial burden on porcine burn wounds decreases after treatment with 0.5% MUC5AC for 7 d. Symbols represent P. aeruginosa PAO1 burden on six individual biopsies collected from two pigs following no treatment (circle), treatment with 0.05% MUC5AC (square) or treatment with 0.5% MUC5AC (triangle). The centre bars indicate the mean bacterial burden. Significance was assessed using Kruskal-Wallis tests followed by Dunn's multiple comparisons test. k, MUC5AC in isolation does not alter P. aeruginosa viability relative to medium alone. Data are mean CFU ± s.e.m., n = 3 biologically independent replicates.
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and less-aggregated planktonic-like state with cells still detectable at ≥50 μm from the glass surface ( Supplementary Fig. 6 ). Collectively, these data highlight two facets of mucin regulatory function-one in which mucins induce a global transcriptional response that 'disarms' P. aeruginosa by downregulating important virulence genes, and another in which mucins suppress aggregation and bacterial attachment to surfaces. Mucin-mediated changes were sufficient to neutralize antagonistic interactions between P. aeruginosa and human cells. By monitoring the survival of human epithelial cells over time, we determined that MUC5AC reduced P. aeruginosamediated epithelial cell death in a dose-dependent manner ( Fig. 2g ) while maintaining the morphology and confluency of the epithelial cell monolayer ( Fig. 2h ).
To better understand the relevance of the regulatory function of mucin in a complex biological system of multiple cell types and an active immune system, we exposed P. aeruginosa-infected porcine burn wounds to a wound dressing containing MUC5AC and quantified the bacterial burden over time by counting colonyforming units (CFU; Fig. 2i , Supplementary Fig. 8 ). Exposure to MUC5AC resulted in two-log reductions in CFU in wounds one week after infection, compared with no reduction in the mucin-free mock treatment (Fig. 2j ). The sustained clearance of P. aeruginosa detected here is probably not due to direct killing by MUC5AC, as viability was not inhibited by mucins in isolation ( Fig. 2k ). Rather, mucin likely mediates bacterial clearance through the regulation of microbial phenotypes, which attenuates pathogens and thereby facilitates host-mediated clearance.
It is tempting to speculate that mucin triggers this phenotypic switch by maintaining cells in the planktonic non-aggregate form. To test this hypothesis, we evaluated whether mucins still suppressed virulence genes in mutants lacking flagellar motility (ΔmotABCD) or the ability to aggregate (Δpslpel; Fig. 3a ). Both mutants responded to mucins (Fig. 3b ), indicating that the virulence-attenuating function of mucin is not a downstream consequence of changes to motility or aggregation, but rather a parallel effect. Integrating our RNA-seq results with the major genetic components of the P. aeruginosa virulence network 8, 9 (Fig. 3c ) revealed that the broad virulenceattenuating effect of mucin probably involves multiple regulatory systems. Polymer solutions such as mucin have complex structural and biochemical properties that could directly or indirectly trigger signalling events through many sensory systems in P. aeruginosa. One possibility is that mucins trigger a general response through their electrostatic or hydrophobic properties or by creating geometric constraints. An alternative hypothesis is that the observed response is triggered by sensing specific biochemical moieties that are presented on secreted mucins. To distinguish between these two possibilities, we tested whether carboxymethylcellulose (CMC)-a well-established mucin mimetic with charge and viscoelastic properties that are similar to those of native mucins 10 -could elicit changes in P. aeruginosa virulence. Importantly, exposure to CMC To determine whether the changes to virulence are caused by a shift in motility or aggregation, we monitored the virulence phenotype of non-motile (ΔmotABCD) and non-aggregative (Δpslpel) mutants after exposure to mucin. b, Downregulation of the expression of virulence genes by mucin does not require a shift in motility or aggregation, indicating that it is a parallel effect of mucin. Data are log 2 -transformed qPCR measurements of relative gene expression ± s.e.m.; n = 3 biologically independent replicates. Significance was assessed using two-tailed t-tests followed by Holm-Sidak correction for multiple comparisons; no significant difference in log 2 [fold change] was found between the WT and mutants. c, The virulence regulon of mucin is downstream of multiple interconnected regulatory cascades. d, CMC does not differentially regulate virulence genes. Data are log 2 -transformed qPCR measurements of relative gene expression ± s.e.m.; n = 3 biologically independent replicates. Significance was assessed using one-sample two-tailed t-tests followed by Bonferroni correction for multiple comparisons; no significant difference in log 2 [fold change] was found between CMC and medium alone. Supplementary  Table 8 . For a-c, similar results were observed in three independent replicates. d, Representative images of GFP-expressing P. aeruginosa biofilms after a 3 h treatment with medium alone, 0.01% mucin glycans or a 0.01% pool of monosaccharides. Glycan solutions reduce biofilm biomass in the WT strain, but not the flagellar mutant (ΔfliD). Similar results were observed in different fields of view across three independent replicates. Scale bar, 20 μm. e, Mucin glycans, but not monosaccharides, disperse biofilm biomass into the planktonic state for the WT strain, but not the flagellar mutant (ΔfliD). Data are mean ± s.e.m.; n = 3 biologically independent replicates. Significance was assessed in relation to the medium-alone control using ordinary one-way ANOVA followed by Dunnett's multiple comparisons test. f, Mucin glycans inhibit bacterial attachment to human epithelial HT-29 cells. The centre line indicates the median, the box limits indicate the upper and lower quartiles and the whiskers indicate 1.5× the interquartile range. Data are from n = 6 (medium alone), n = 3 (MUC5AC glycans) and n = 6 (monosaccharides) biologically independent replicates. Significance was assessed in relation to the medium-alone control using ordinary one-way ANOVA, followed by Dunnett's multiple comparisons test. g, Relative size distributions of aggregates were identified using live 3D confocal microscopy and analysed using IMARIS. In medium alone and medium with monosaccharides, P. aeruginosa biomass is concentrated in large surface-associated aggregates, whereas MUC5AC glycans suppress the formation of aggregates. 
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Nature Microbiology did not differentially regulate signature virulence genes (Fig. 3d ), prevent surface attachment ( Supplementary Fig. 9 ) or protect epithelial cells from P. aeruginosa-induced death ( Supplementary  Fig. 9 ). These results suggest that the polymeric structure of mucin is not sufficient to mediate these virulence-attenuating effects. Rather, specific biochemistry that is present in mucins, but not in CMC, is necessary to attenuate P. aeruginosa virulence. Native mucins display a plethora of complex glycan structures that are covalently linked to serine and threonine [11] [12] [13] , creating a wealth of biochemical information with the potential to influence microbial gene expression. P. aeruginosa uses many strategies to sense and respond to host signals, enabling it to coordinate the switch between its pathogenic and host-compatible states 8, 9 . The sensing of signature mucin-glycan motifs may be an effective mechanism to limit the production of metabolically costly virulence factors in niches in which virulence would not be advantageous. The potential of complex mucin glycans to regulate microbial behaviour has been largely overlooked owing to fundamental technical limitations, including the difficulty of purifying intact mucins, nonstandard methods for isolating O-linked glycans and the analytical complexity of predicting glycan structures 14 . To determine whether glycans contribute to the virulence-neutralizing capability of mucin, we assessed the degree to which glycans isolated from the MUC5AC protein backbone recapitulate the mucin response in P. aeruginosa. We isolated mucin glycans by alkaline β-elimination, which preserved the unique sequences in the oligosaccharide chains and yielded a pooled library of O-linked glycans (Fig. 4a,b ). We then analysed glycans using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF). After processing for annotation and assignment on the basis of mass and known core structures, we identified >90 glycan structures ( Fig. 4c, Supplementary Table 8 ), not including distinct isomeric forms, which would probably increase the library diversity to several hundred structures. The diversity of our glycan library is comparable to those of published libraries for mammalian gastric and respiratory mucins [11] [12] [13] 15 . Specifically, glycans in our library were predominantly built on core-2 (Galβ1-3(GlcNAcβ1-6)GalNAcα1-) and, to a lesser extent, core-1 (Galβ1-3GalNAcα1-) structures, with a high level of fucosylation and relatively little sialylation [11] [12] [13] 15 , where hyphens refer to the glycosidic linkages between sugar monomers.
Like native mucus and intact mucins, mucin glycans triggered the active motility-dependent dispersal of bacterial cells from mature biofilms ( Fig. 4d, Supplementary Fig. 10 ) into the planktonic state ( Fig. 4e ). Mucin glycans also prevented bacterial attachment to glass surfaces ( Supplementary Fig. 11 ) and to human cells ( Fig. 4f ) and yielded bacterial aggregates smaller than those formed in medium alone or with monosaccharides ( Fig. 4g) . To determine the mucin-regulated pathways that were specifically altered in response to mucin glycans, we exposed P. aeruginosa to a pool of potential glycan cues and monitored changes in gene expression. RNAseq revealed that P. aeruginosa that was exposed to relatively low concentrations (0.01% w/v) of free MUC5AC glycans undergoes a transcriptional response that mirrors that associated with exposure to 0.5% (w/v) whole native mucin that comprised up to 0.4% (w/v) grafted glycans (Fig. 4h ). Functional enrichment analyses confirmed that the same virulence pathways suppressed by intact MUC5AC were also suppressed by MUC5AC glycans (Fig. 4i ), further indicating that an integral part of mucin, rather than another mucus-associated factor, is the primary virulence-neutralizing agent in mucus. We anticipate that increasing the glycan concentration to levels present on mucin will improve the dynamic range of the transcriptional response. Importantly, the viability of P. aeruginosa was not altered by the presence of monosaccharides that are present in mucin glycans (Fig. 4j ). Exposure of P. aeruginosa to a pool of these monosaccharides did not trigger dispersal (Fig. 4d,e ), prevent attachment to glass ( Supplementary Fig. 11 ) or human cells (Fig. 4f ), or differentially regulate quorum sensing (lasR), siderophore production (pvdA) or type-3 secretion (pcrV) genes (Fig. 4k ). Monosaccharide exposure also did not suppress the production of virulence factors, even with increasing concentrations of monosaccharides ( Supplementary Fig. 12 ), although a non-significant effect on bacterial burden in vivo was detected ( Fig. 4l ). On the basis of these data, we conclude that the complex arrangement and particular stereochemistry of these sugar residues are critical to their function as regulatory signals.
The diversity of O-linked glycans on mucins exceeds even that on tissue surfaces [16] [17] [18] , and their complexity makes them ideal for encoding biological information with a high degree of specificity. In this way, mucins present and retain a myriad of potential regulatory cues. We propose that microorganisms probably evolved mechanisms to recognize, process, uptake and respond to specific moieties within the complex array of mucin glycans 19 . The question remains as to how mucin glycans interact with, and are sensed by, P. aeruginosa at the molecular level. One possibility is that glycans directly serve as a signal through a carbohydrate binding site in a global regulatory system, such as those affecting the secondary messenger c-di-GMP or the non-coding RNAs rsmY and rsmZ 8, 9 . Potential glycan sensors have been identified in P. aeruginosa that are thought to feed into regulatory virulence pathways and have annotated carbohydrate binding sites, such as the two-component sensor LadS and the diguanyulate cyclase NicD 20, 21 . Mucin glycans may also trigger metabolic changes by serving as a nutritional substrate, or regulate signalling pathways through interactions with specific P. aeruginosa lectins or surface adhesins. We speculate that the structural diversity of mucins and mucin-associated glycans enables them to interact with several bacterial receptors and mediate distinct functions.
Collectively, our findings reveal a previously unrecognized role for mucin glycans as potent host-derived regulators of a bacterial phenotype that has broad implications for how the body prevents mucosal infections while maintaining a diverse microbiota. The reason why diseased mucus no longer retains the ability to attenuate virulence [22] [23] [24] [25] [26] remains an open question. Based on our findings that glycans trigger a switch in bacterial phenotype, we postulate that changes to mucin glycosylation patterns in disease, such as increased sialylation 15 , will alter both the binding properties of mucin with microorganisms and its protective function. By isolating a mucinglycan library, we have established the conceptual and technical framework to systematically address these open questions about the glycan regulatory code. We posit that cracking this code will explain the influence of glycans on the virulence of microorganisms that interact with the host through mucosal surfaces. Identification of specific bioactive glycans will likely reveal a class of therapeutics for treating intractable bacterial infections and may inspire treatment strategies that tune host glycan signals to attenuate virulence and stabilize the healthy microbiota.
Methods
Strains and growth conditions. Batch cultivation of P. aeruginosa strains (Supplementary Table 9 ) was carried out under shaking at 37 °C in Luria-Bertani broth (LB; Difco). Gentamicin (30 μg ml −1 ) was added to the medium for strains with gentamicin-resistant plasmids.
For whole-mucus experiments, overnight cultures of PAO1 were diluted tenfold in ABTGC (ABT minimal medium, described previously 27 , supplemented with 5 g glucose and 5 g casamino acids) and grown for 4 h. Then, 75 μl of these cultures was exposed to 75 μl of solubilized mucus or solubilization buffer (described in the 'Preparation of whole mucus' section) for 1 h at 37 °C in a static 96-well microtitre plate (Cellstar).
For experiments involving liquid culture, overnight cultures of PAO1 were diluted to an OD 600 of 0.01 in 150 μl ABTGC with or without MUC5AC (0.01%-0.5%), MUC5B (0.5%), CMC (0.5%; Sigma), MUC5AC glycans (0.01%) or monosaccharide mixture (0.01%), and grown for 5 h at 37 °C in a static 96-well microtitre plate. Note that, on the basis of the data shown in Fig. 4b , the monosaccharide mixture contained equal weights of galactose, N-acetylglucosamine, N-acetylgalactosamine, fucose and sialic acid (all of the sugars were obtained from Sigma). The concentration of glycans was selected on the basis of the mucin dose response curves shown in Fig. 2 ; in these experiments, we found that 0.01% was the lowest mucin concentration with measurable effects (Fig. 2f ). Owing to the technical challenges of preparative-scale purification of mucin glycans, we used the minimal inhibitory concentration in this research.
Collection of human saliva. Submandibular saliva was collected from human volunteers using a custom vacuum pump, pooled, centrifuged at 2,500g for 5 min and protease inhibitors were added as previously described 28 . Samples of human saliva were collected after explaining the nature and possible consequences of the studies, obtaining informed consent and receiving approval from the institutional review board and Massachusetts Institute of Technology's Committee on the Use of Humans as Experimental Subjects under protocol no. 1312006096.
Preparation of whole mucus. Mucus was scraped from fresh pig stomachs and intestines and solubilized (1 g scrapings in 5 ml) in 0.2 M sodium chloride buffer with protease inhibitors (5 mM benzamidine hydrochloride, 1 mM dibromoacetophenone, 1 mM phenylmethylsulfonylfluoride and 5 mM EDTA, pH 7) and 0.04% sodium azide (Sigma). Cellular debris and food waste was removed using low-speed centrifugation at 8,000g (7,000 r.p.m., Sorvall GS-3 rotor) for 30 min at 4 °C.
Mucin purification. This study used native porcine gastric mucins (MUC5AC), porcine intestinal mucins (MUC2) and human salivary mucins (MUC5B), which differ from industrially purified mucins in their rheological properties and bioactivity 4, 5, [28] [29] [30] . Native mucins were purified as described previously 4, [28] [29] [30] [31] . In brief, mucus was scraped from fresh pig stomachs and intestines, solubilized in sodium chloride buffer (described above) and insoluble material was removed by ultracentrifugation at 190,000g RCF for 1 h at 4 °C (40,000 r.p.m., Beckman 50.2 Ti rotor with polycarbonate bottles). Submandibular saliva was collected from human volunteers using a custom vacuum pump, pooled, centrifuged and protease inhibitors were added 28 . Mucins were purified using size-exclusion chromatography on separate Sepharose CL-2B columns. Mucin fractions were then desalted, concentrated and lyophilized for storage at −80 °C. Lyophilized mucins were reconstituted by shaking gently at 4 °C overnight in the desired medium. Mass spectrometry is routinely used to monitor the composition of purified mucin extracts 30, 31 . This type of analysis has shown that mucin extracts purified from porcine stomach mucus, for example, are composed predominantly of MUC5AC, with small quantities of MUC2, MUC5B and MUC6, as well as histones, actin and albumin 30, 31 .
Isolation of mucin oligosaccharide.
Here we applied non-reductive alkaline β-elimination ammoniolysis to dissociate non-reduced glycans from mucins 32 . Purified mucins were dissolved in ammonium hydroxide saturated with ammonium carbonate and incubated at 60 °C for 40 h to release oligosaccharide glycosylamines and partially deglycosylated mucins. Volatile salts were removed using repeated centrifugal evaporation and the oligosaccharide glycosylamines were separated from residual deglycosylated mucins by centrifugal filtration through 3-5 kDa molecular weight cut-off membranes in accordance with the manufacturer's instructions (Amicon Ultracel). The resulting oligosaccharide glycosylamines were converted to reducing oligosaccharide hemiacetals by treatment with boric acid. Residual boric acid was removed by repeated centrifugal evaporation from methanol. Oligosaccharides were further purified using solidphase extraction using Hypercarb mini-columns (ThermoFisher) and residual solvents were removed through centrifugal evaporation 33 .
Capillary electrophoresis of oligosaccharides. Reducing oligosaccharides released from mucins were labelled by reductive amination using the fluorescent tag 8-aminopyrene-1,3,6-trisulfonic acid, sodium cyanoborohydride and citric acid. Labelled oligosaccharides were analysed using polyvinylalcohol coated N-CHO capillaries in accordance with the manufacturer's (SciEx/Beckman) protocol using a PA800 (Beckman) capillary electrophoresis instrument, detected with laser-induced fluorescence and analysed using the 32 Karat software. The relative sizes of separated oligosaccharides were determined by comparison with the migration times of glucose polymer standards. Chromatograms were constructed in GraphPad Prism (v.7.04).
Capillary electrophoresis of monosaccharides. The monosaccharide composition of released mucin glycans was determined using established methods 34, 35 . In brief, neutral monosaccharides were obtained by hydrolysis in trifluoracetic acid for 1 h at 80 °C. The liberated monosaccharides were labelled with 8-aminopyrene-1,3,6-trisulfonic acid using reductive amination as described for oligosaccharides. Monosaccharides were analysed with capillary electrophoresis on a bare silica column and detected using laser-induced fluorescence. Monosaccharides were identified and quantified by comparison with a maltose internal standard, and migrations times and standard curves were generated using purified standard sugars. Chromatograms were constructed in GraphPad Prism (v.7.04).
MALDI-TOF and prediction of mucin-glycan structure. β-Eliminated glycans were permethylated and analysed at the Glycomics Core at Beth Israel Deaconess Medical Center as previously described 36 . Mass spectrometry data were acquired using an UltraFlex II MALDI-TOF mass spectrometer (Bruker Daltonics). The reflective positive mode was used, and data were recorded between 500 m/z and 6,000 m/z. The mass spectrometry O-linked glycan profile was acquired by aggregating at least 20,000 laser shots. Mass peaks were manually annotated and assigned to a particular O-linked glycan composition on the basis of known core structures.
RNA preparation. Total RNA was extracted using the MasterPure RNA Purification kit (Lucigen) and residual DNA was removed using the Turbo DNA-free kit (Ambion). The integrity of the total RNA was assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies). 16S, 23S and 5S rRNA were removed using the Ribo-Zero Magnetic Kit (Bacteria; Epicentre).
RNA-seq. Gene expression analysis was performed using Illumina RNA-seq. RNA-seq was conducted for three biological replicates. The libraries were produced using the KAPA RNA HyperPrep kit (Kapa Biosystems). The libraries were sequenced using the Illumina HiSeq platform with a single-end protocol and read lengths of 40 or 50 nucleotides.
Analysis of sequencing data. Sequencing reads were mapped onto the P. aeruginosa PAO1 reference genome, which is available for download from the Pseudomonas Genome Database (http://www.pseudomonas.com) using the Galaxy server 37 . Gene expression values were normalized on the basis of library size and differentially expressed genes were identified using a negative binomial test with an FDR-adjusted P < 0.05. Expression changes in signature virulence genes identified by RNA-seq were validated using qPCR, which revealed strong concordance between the two methods ( Supplementary Fig. 4 ).
Functional category (pathway) assignments were downloaded from the Pseudomonas Genome Database. Pathway enrichment analysis was performed in MATLAB (R2016b) using one-sided Mann-Whitney U-tests, for which ranking was calculated on the basis of the log 2 -transformed fold change.
Heat maps and scatter plots of gene expression data were constructed using GraphPad Prism. Principle component analysis was performed in R (v.3.4.0) using the DESeq2 workflow 38 . For all analyses of the sequencing data, P values were adjusted for multiple comparisons using Benjamini-Hochberg correction to obtain FDR-adjusted P values.
RT-qPCR analysis.
A list of the primers used in this study is provided in Supplementary Table 9 . qPCR with reverse transcription (RT-qPCR) was performed using a two-step method. First-strand cDNA was synthesized from total RNA using the ProtoScript II First Strand cDNA Synthesis kit (NEB). The cDNA was used as a template for RT-qPCR using a SYBR PowerUp Master Mix kit (Applied Biosystems by Life Technologies) on a Roche LightCycler 480 realtime PCR system. Primers for RT-qPCR were designed on the basis of previously published literature or using the NCBI Primer-BLAST tool (https://www.ncbi.nlm. nih.gov/tools/primer-blast/). The genes rpoD and proC were used as endogenous controls. The elimination of contaminating DNA was confirmed using qPCR amplification of rpoD on control samples that did not have reverse transcriptase added during cDNA synthesis. Melting-curve analyses were used to verify singleproduct amplification. Changes in gene expression were calculated on the basis of mean change in qPCR cycle threshold (∆Ct) using the ∆∆C t method (fold change = 2 ÀΔΔCt I ).
Dispersal of static P. aeruginosa biofilms. Under static conditions, P. aeruginosa biofilm dispersal was assayed as previously described 4 , with slight modifications. In brief, an overnight culture of PAO1-GFP or PAO1-GFP ΔfliD was diluted in ABTGC medium to an initial OD 600 of 0.01, added to a glass-bottom or plastic 96-well plate and incubated for 48 h at 37 °C under static conditions. The supernatant containing non-adherent cells was removed from the plate and the biofilm remaining in each well was washed at least three times with 0.9% NaCl. The biofilms were exposed to whole mucus, the solubilization buffer, ABTGC medium alone, or ABTGC medium containing either 0.01% mucin glycans or monosaccharides. The biofilms were statically incubated at 37 °C for 3 h. The plates were washed three times with 0.9% NaCl and resuspended in ABTGC medium, then examined using microscopy to determine the remaining biofilm biomass. Viable dispersed cells were quantified using CFU counts on LB agar plates. Image acquisition was performed using a confocal laser scanning microscope (LSM 800, Zeiss) equipped with a ×63/1.4 NA oil-immersion or a ×100/1.4 NA oil-immersion objective. The excitation wavelength for GFP was 488 nm. At least five stacks were recorded for each well and at least three independent wells. Biofilm quantification was performed using IMARIS (v.7.7.2).
Measurement of protease activity. Bacterial cultures were pelleted by centrifugation (13,200g for 3 min at room temperature), and the supernatants were filter-sterilized using 0.2 μm filters.
Protease IV activity. The activity of protease IV in cell-free culture supernatants was measured by breakdown of the chromogenic substrate Chromozym PL (Roche), which reacts specifically with protease IV in P. aeruginosa culture supernatants 39 . In brief, 10 µl pretreated sample and 3 µl Chromozym PL (7 mM) were combined in reaction buffer (20 mM Tris-HCl, pH 8.0) to a total volume of 100 µl in a microwell plate. The plates were assayed on a SpectraMax M Series Multi-Mode Microplate Reader (Molecular Devices) pre-equilibrated to 30 °C by measuring the rate of increase in absorbance at 405 nm at 3 min intervals for 30 min. Protease IV activity was calculated using the following equation:
F´E´d´ΔA=min where F is the dilution factor, E is the extinction coefficient (which is 10.4 at 405 nm), d is the path length (at 100 µl volume in a microtitre plate, path length ≈ 0.53 cm) and ΔA/min is the maximum change in absorbance min −1 . The protease activity was normalized to account for variation in bacterial cell growth on the basis of the OD 600 of the culture at 5 h. Relative changes were calculated on the basis of the protease activity in medium alone.
Alkaline protease activity. Alkaline protease activity was tested using a modified method that was described previously 40 . Samples containing 1 mg of Hide powder azure (Sigma) dissolved in buffer (0.075 ml) consisting of 20 mM Tris-HCl, pH 8.0 and 1 mM CaCl 2 were mixed with 0.025 ml of the culture supernatants. The reaction mixtures (0.1 ml) were incubated at 37 °C for 1 h. Undissolved substrate was removed by centrifugation at 4,000g for 5 min. The absorbance of the reaction mixtures was determined at 595 nm using a SpectraMax M Series Multi-Mode Microplate Reader (Molecular Devices). Protease activity was expressed in terms of protease U ml −1 , where one unit is equivalent to an increase of 1.0 OD 595 h −1 at 37 °C. Protease activity was normalized to account for variation in bacterial cell growth on the basis of the OD 600 of the culture at 5 h. Relative changes were calculated on the basis of the protease activity in the medium alone.
Measurement of siderophore fluorescence. Pyoverdine and pyochelin levels were simultaneously quantified on the basis of characteristic fluorescence spectra, as previously described 41 . In brief, fluorescence was measured on a SpectraMax M Series Multi-Mode Microplate Reader (Molecular Devices). Pyoverdine production was quantified using an excitation wavelength of 400 nm and an emission wavelength of 460 nm. Pyochelin fluorescence was quantified using an excitation wavelength of 350 nm and an emission wavelength of 410 nm. To account for the background fluorescence of pyoverdine, pyochelin production was calculated using the following equation:
where z is the actual value of pyochelin production, w is the fluorescence measured at an excitation/emission of 350 nm/410 nm and y is the pyoverdine fluorescence measured at an excitation/emission of 400 nm/460 nm.
Quantification of bacterial growth and polystyrene-attached biomass.
Growth curves were measured in microtitre plates on a SpectraMax M Series Multi-Mode Microplate Reader (Molecular Devices) by measuring the absorbance at 600 nm (OD 600 ) and by CFU counts. Adherent biomass was quantified using crystal violet 42 . Cells attached to the wells of the plate were washed three times with 0.9% NaCl and stained with 0.01% crystal violet for 15 min at room temperature. The wells were then washed three times with 0.9% NaCl and ethanol was then added to each well. After 15 min, crystal violet staining was quantified by measuring absorbance at 595 nm (OD 595 ) and then normalized to the density of the culture (OD 600 ) at 5 h.
Human cell culture. Authenticated mycoplasma-free HT-29 cells (ATCC, HTB38), a human carcinoma cell line with epithelial morphology, were obtained directly from the American Type Culture Collection (ATCC). Cell morphology was routinely monitored to verify cell-line authenticity, and cells were periodically tested for contamination by PCR. The cells were cultured in DMEM with GlutaMAX (Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco) at 37 °C in 5% CO 2 and 95% air. Cells were split 1:12 and passaged as the culture reached confluence. To prepare for co-culture with bacteria, HT-29 cells were detached from the growth surface with 0.25% trypsin and 1 mM EDTA (Gibco), resuspended in DMEM and FBS, counted, diluted to the appropriate density in DMEM and FBS, and seeded in 96-well plates to confluence (approximately 5 × 10 5 HT-29 cells).
Examination of bacterial interactions with epithelial cells.
In all of the experiments, control and experimental HT-29 cells were treated identically except that the co-culture medium did not contain bacteria in the uninfected controls. Bacteria were co-cultured with HT-29 cell monolayers at an initial multiplicity of infection of 20 (1 × 10 7 CFU) for 1-8 h. Subsequently, HT-29 cells were processed and assayed in the cell-function assays described below.
Analysis of bacterial attachment. After 1 h of co-culture, non-adherent bacteria in the supernatant were aspirated and quantified by serial dilution as CFUs. HT-29 cell monolayers were washed three times with phosphate-buffered saline (PBS, Gibco) and cells were lysed with 1% Triton X-100 (Sigma) and removed from the growth surface. The attached bacteria were serially diluted in PBS and quantified as CFUs.
Epithelial cytotoxicity assay. The killing of HT-29 cells by P. aeruginosa was measured using the membrane-impermeable nuclear stain propidium iodide, which enables continuous quantitative measurement of cell viability over time owing to its optimal linear DNA-binding, without background from bacterial cell death ( Supplementary Fig. 14) . After co-culture for 1-10 h, propidium iodide fluorescence (excitation/emission 535 nm/617 nm) was measured using a SpectraMax M Series Multi-Mode Microplate Reader (Molecular Devices). Between measurements, plates were kept in an incubator at 37 °C, 5% CO 2 and 95% air. At the end of the experiment, maximal fluorescence was measured following treatment of each well with 1% Triton X-100 to permeabilize all cells and label all nuclei with propidium iodide, which corresponds to 100% cell death. Background fluorescence of propidium iodide was measured in uninfected control cells (exposed to medium alone or the appropriate concentration of MUC5AC) at the beginning of the experiment. Percentage cytotoxicity was calculated as:
where f 0 is the initial fluorescence, M is the maximum fluorescence after addition of Triton X-100 and f is the fluorescence at any given time. Mucin dose response curves were assessed at 7.5 h. 
Examination of bacterial interactions with porcine burn wounds.
Interactions between P. aeruginosa and full-thickness burn wounds were assessed as previously described 43, 44 . In brief, female Yorkshire pigs (n = 4) weighing between 32 and 36 kg were anaesthetized and the dorsal trunk was shaved and surgically prepared. Under aseptic conditions, six 5.08 × 5.08 cm full-thickness burn wounds were created on the back of the pig using an electrically heated burn device with controlled pressure delivery for 50 s. One day after the thermal injury, mid-log phase cultures of P. aeruginosa were topically inoculated onto the wound site at a concentration of 1 × 10 8 CFU in 250 μl of 20% PF-127 (Sigma) prepared in PBS with 0%, 0.05% (0.5 mg ml −1 ) or 0.5% (5.0 mg ml −1 ) MUC5AC, or 0.01% (0.1 mg ml −1 ) MUC5AC glycans or monosaccharides. The inoculated and treated wound was rubbed with a sterile spatula for 30 s. On days 1 and 4 after inoculation, treatment was reapplied to the wound. On days 1 and 7 after inoculation, full-thickness wound-tissue biopsies were collected for microbiological analysis using a 6 mm sterile disposable punch biopsy tool. Treatments for each wound site were randomized, and were not performed blinded. Viable bacterial counts were determined from three randomly selected 6 mm punch biopsies from each wound site. Biopsies were weighed and placed in separate sterile polypropylene culture test tubes containing 1 ml of PBS. All of the samples were homogenized using a Pro Scientific Bio-Gen Series Pro200 hand-held homogenizer for 45 s. The resulting solutions were serially diluted and plated on Pseudomonas isolation agar (Difco) with rifampicin (100 μg ml −1 ) in at least triplicate and incubated at 37 °C overnight. CFUs were calculated per gram of tissue.
Calculation of sample size. Statistical experts in the OSU Center for Biostatistics performed sample size calculations on the basis of power analyses. To determine the minimum sample sizes necessary to detect some of the effects under investigation, data from previous preliminary studies were used. Although power analysis (based on α = 0.05, two-tailed tests) indicated that six animals per group would be required to achieve statistical significance, 1-2 animals per group showed significant effects. As the data were not normally distributed, nonparametric Kruskal-Wallis one-way ANOVA was used. All care of laboratory animals was in accordance with institutional guidelines, and approved by the Ohio State University Institutional Animal Care and Use Committee (IACUC) under protocol 2012A00000041-R1.
Statistical analysis. Unless noted otherwise, experiments were performed with at least three biological replicates consisting of at least three technical replicates, and results are presented as mean ± s.e.m. Statistical significance was assessed using ordinary one-way ANOVA followed by Dunnett's multiple comparisons test, or one-sample Student's t-tests for normalized data unless otherwise noted. Adjusted P values of <0.05 were considered to be significant. 
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